Observe Medical ASA (OSL:OBSRV) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:OBSRV Observe Medical ASA OSL:OBSRV
29 GF Score
Price kr0.96
GF Value kr0.20
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Observe Medical ASA Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

OSL:OBSRV
29GF Score
Observe Medical ASA OSL:OBSRV
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Observe Medical ASA (OSL:OBSRV) Overvalued in 2026?

Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued. The current stock price of kr0.96 is trading 379% above its estimated GF Value™ of kr0.20. GuruFocus considers Observe Medical ASA to be Significantly Overvalued.

Key valuation signals for OSL:OBSRV:

  • Interest Received:
  • GF Value™: kr0.20 vs. price of kr0.96 (379% above fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the OSL:OBSRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Observe Medical ASA Business Description

Other Exchanges OM50:Germany
Address Dronning Eufemias gate 16, Oslo, NOR, 0191
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
29GF Score

Get the complete analysis for OSL:OBSRV

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.96
Price
kr0.20
GF Value